Trevi Therapeutics Aktie
12,81
USD
+0,87
USD
+7,29
%
12,83
USD
+0,90
USD
+7,54
%
Werbung
Trevi Therapeutics Aktie Analyse
| 03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
| 03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung